In the present work, we tested the causal effects of anti-TNF on CAD and IS susceptibility using MR design and found no evidence for any benefits of inhibiting the TNF/TNFR1 signalling pathway on either disease. The gene discussed is TNF; the disease is coronary artery disorder.